Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes

Area of Science:

• Neuroscience
• Stem Cell Biology
• Developmental Biology

Background:

• Astrocytes are crucial glial cells in the central nervous system, involved in brain function and disease.
• Current methods for differentiating human stem cells into astrocytes yield immature cells, limiting their utility for research.
• Understanding astrocyte development and function is vital for neurological research and disease modeling.

Purpose of the Study:

• To develop an efficient protocol for generating mature spinal cord astrocytes from human stem cells.
• To investigate the effects of specific growth factors and cytokines on astrocyte differentiation and maturation.
• To establish scalable, phenotypically defined astrocyte populations for in vitro studies.

Main Methods:

• Utilized early neuralization of mouse or human embryonic and induced pluripotent stem cells.
• Applied short exposures to fibroblast growth factor 1 (FGF1) or FGF2 to direct astrocyte maturation.
• Analyzed astrocyte phenotype using marker expression and functional assays.
• Investigated the impact of tumor necrosis factor alpha and interleukin-1β on astrocyte characteristics.

Main Results:

• Achieved high-efficiency generation of spinal cord astrocytes from various stem cell sources.
• Demonstrated that brief FGF1 or FGF2 treatment effectively induced a mature, quiescent astrocyte phenotype.
• Showed that tumor necrosis factor alpha and interleukin-1β induced inflammatory markers but did not promote maturation.
• Characterized phenotypically distinct astrocyte populations.

Conclusions:

• Developed a novel method for generating mature, functional spinal cord astrocytes from human stem cells.
• Identified specific growth factors (FGF1, FGF2) that promote astrocyte maturation.
• Established valuable in vitro models for studying normal astrocyte function and neurological diseases.